An Observational, Cross-Sectional Survey to Assess PML Risk Awareness and Understanding from Patients’ Perspective and Effectiveness of the Tysabri (Natalizumab) Patient Alert Card in the UK (T-PAC) First published 12/09/2023 Last updated 12/07/2024 EU PAS number:EUPAS106690 Study Finalised